D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 72 Citations 18,539 146 World Ranking 945 National Ranking 32
Medicine D-index 84 Citations 32,685 203 World Ranking 7878 National Ranking 245

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Immune system

S. J. H. Van Deventer focuses on Internal medicine, Tumor necrosis factor alpha, Immunology, Cytokine and Endocrinology. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Recombinant DNA. His biological study spans a wide range of topics, including Sepsis, Coagulation, Escherichia coli, Fibrinolysis and Necrosis.

His Immunology research includes themes of Inflammatory bowel disease, Coagulopathy and Tuberculosis. His studies deal with areas such as Whole blood and Immune system as well as Cytokine. The concepts of his Endocrinology study are interwoven with issues in CD14, Thrombin and In vivo.

His most cited work include:

  • Infliximab for the treatment of fistulas in patients with Crohn's disease. (2257 citations)
  • Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). (1030 citations)
  • Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways (758 citations)

What are the main themes of his work throughout his whole career to date?

S. J. H. Van Deventer spends much of his time researching Immunology, Internal medicine, Tumor necrosis factor alpha, Cytokine and Crohn's disease. S. J. H. Van Deventer interconnects Disease and Inflammatory bowel disease in the investigation of issues within Immunology. His Internal medicine study incorporates themes from Gastroenterology and Endocrinology.

His Tumor necrosis factor alpha research includes themes of Pathogenesis, Neutrophil degranulation, Necrosis, Antibody and Pharmacology. His Cytokine research incorporates themes from Proinflammatory cytokine and Lymph. S. J. H. Van Deventer has included themes like Surgery, Infliximab and Immunotherapy in his Crohn's disease study.

He most often published in these fields:

  • Immunology (46.25%)
  • Internal medicine (32.81%)
  • Tumor necrosis factor alpha (26.88%)

What were the highlights of his more recent work (between 2001-2013)?

  • Immunology (46.25%)
  • Internal medicine (32.81%)
  • Crohn's disease (16.60%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Immunology, Internal medicine, Crohn's disease, Disease and Gastroenterology. In most of his Immunology studies, his work intersects topics such as Inflammatory bowel disease. His biological study spans a wide range of topics, including Endocrinology and Surgery.

His Crohn's disease research incorporates elements of Infliximab, Peripheral blood and Microbiology. The Gastroenterology study combines topics in areas such as Dysplasia, Ulcerative colitis, Differential diagnosis, Biopsy and Colonoscopy. As part of the same scientific family, he usually focuses on Tumor necrosis factor alpha, concentrating on Sepsis and intersecting with Interleukin 6, Disseminated intravascular coagulation, Fibrinolysis and Anticoagulant.

Between 2001 and 2013, his most popular works were:

  • Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. (479 citations)
  • Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets (335 citations)
  • Efficacy and long term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open label trial (272 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Immune system

His primary areas of study are Internal medicine, Gastroenterology, Immunology, Ulcerative colitis and Surgery. His Internal medicine study frequently links to other fields, such as Endocrinology. S. J. H. Van Deventer has researched Gastroenterology in several fields, including Differential diagnosis, Biopsy, Radiology, Endoscopy and Colonoscopy.

His Immunology study integrates concerns from other disciplines, such as Intestinal mucosa and Programmed cell death. His Ulcerative colitis research is multidisciplinary, incorporating perspectives in Laparoscopic surgery, Enema and Peripheral blood mononuclear cell. His study in Cytokine is interdisciplinary in nature, drawing from both Tumor necrosis factor alpha, Proinflammatory cytokine, Colitis and Inflammatory bowel disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Infliximab for the treatment of fistulas in patients with Crohn's disease.

D.H. Present;P.J. Rutgeerts;S.R. Targan;S.B. Hanauer.
The New England Journal of Medicine (1999)

3136 Citations

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

H. M. Van Dullemen;S. J. H. Van Deventer;D. W. Hommes;H. A. Bijl.
Gastroenterology (1995)

1342 Citations

Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways

S. J. H. Van Deventer;H. R. Buller;J. W. Ten Cate;L. A. Aarden.
Blood (1990)

1052 Citations

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.

Geert D'Haens;S Van Deventer;R Van Hogezand;D Chalmers.
Gastroenterology (1999)

864 Citations

Activation of coagulation after administration of tumor necrosis factor to normal subjects.

T. van der Poll;H. R. Büller;H. ten Cate;C. H. Wortel.
The New England Journal of Medicine (1990)

807 Citations

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

T ten Hove;C van Montfrans;M P Peppelenbosch;S J H van Deventer.
Gut (2002)

676 Citations

Tumour necrosis factor and Crohn's disease.

S.J.H. van Deventer.
Gut (1997)

607 Citations

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group.

S.J.H. van Deventer;C.O. Elson;R.N. Fedorak.
Gastroenterology (1997)

516 Citations

Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets

D W Hommes;M P Peppelenbosch;S J H van Deventer.
Gut (2003)

510 Citations

Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees

M Levi;H ten Cate;K A Bauer;T van der Poll.
Journal of Clinical Investigation (1994)

505 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing S. J. H. Van Deventer

Tom van der Poll

Tom van der Poll

University of Amsterdam

Publications: 145

Paul Rutgeerts

Paul Rutgeerts

KU Leuven

Publications: 136

William J. Sandborn

William J. Sandborn

University of California, San Diego

Publications: 117

Stefan Schreiber

Stefan Schreiber

Kiel University

Publications: 106

Severine Vermeire

Severine Vermeire

KU Leuven

Publications: 106

Marcel Levi

Marcel Levi

University College London Hospitals NHS Foundation Trust

Publications: 102

Stephen B. Hanauer

Stephen B. Hanauer

Northwestern University

Publications: 78

Markus F. Neurath

Markus F. Neurath

University of Erlangen-Nuremberg

Publications: 74

Brian G. Feagan

Brian G. Feagan

University of Western Ontario

Publications: 71

Jean-Frederic Colombel

Jean-Frederic Colombel

Icahn School of Medicine at Mount Sinai

Publications: 66

Gary R. Lichtenstein

Gary R. Lichtenstein

University of Pennsylvania

Publications: 63

Gert Van Assche

Gert Van Assche

KU Leuven

Publications: 56

Silvio Danese

Silvio Danese

Humanitas University

Publications: 51

Laurent Peyrin-Biroulet

Laurent Peyrin-Biroulet

University of Lorraine

Publications: 50

Stephan R. Targan

Stephan R. Targan

Cedars-Sinai Medical Center

Publications: 47

Gerhard Rogler

Gerhard Rogler

University of Zurich

Publications: 46

Something went wrong. Please try again later.